321 related articles for article (PubMed ID: 23543553)
1. Long-term effects of weight-reducing drugs in hypertensive patients.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Siering U; Semlitsch T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007654. PubMed ID: 23543553
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of weight-reducing drugs in hypertensive patients.
Siebenhofer A; Horvath K; Jeitler K; Berghold A; Stich AK; Matyas E; Pignitter N; Siering U
Cochrane Database Syst Rev; 2009 Jul; (3):CD007654. PubMed ID: 19588440
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T
Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of weight-reducing drugs in people with hypertension.
Siebenhofer A; Winterholer S; Jeitler K; Horvath K; Berghold A; Krenn C; Semlitsch T
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD007654. PubMed ID: 33454957
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
6. Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.
Johansson K; Sundström J; Neovius K; Rössner S; Neovius M
Obes Rev; 2010 Nov; 11(11):777-91. PubMed ID: 20025693
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of weight-reducing diets in hypertensive patients.
Siebenhofer A; Jeitler K; Berghold A; Waltering A; Hemkens LG; Semlitsch T; Pachler C; Strametz R; Horvath K
Cochrane Database Syst Rev; 2011 Sep; (9):CD008274. PubMed ID: 21901719
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis.
Johansson K; Neovius K; DeSantis SM; Rössner S; Neovius M
Obes Rev; 2009 Sep; 10(5):564-75. PubMed ID: 19460116
[TBL] [Abstract][Full Text] [Related]
9. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
10. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2004; 2003(3):CD004094. PubMed ID: 15266516
[TBL] [Abstract][Full Text] [Related]
11. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.
Ara R; Blake L; Gray L; Hernández M; Crowther M; Dunkley A; Warren F; Jackson R; Rees A; Stevenson M; Abrams K; Cooper N; Davies M; Khunti K; Sutton A
Health Technol Assess; 2012; 16(5):iii-xiv, 1-195. PubMed ID: 22340890
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of weight-reducing diets in people with hypertension.
Semlitsch T; Jeitler K; Berghold A; Horvath K; Posch N; Poggenburg S; Siebenhofer A
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008274. PubMed ID: 26934541
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of weight-reducing diets in people with hypertension.
Semlitsch T; Krenn C; Jeitler K; Berghold A; Horvath K; Siebenhofer A
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD008274. PubMed ID: 33555049
[TBL] [Abstract][Full Text] [Related]
14. Rimonabant for the treatment of overweight and obese people.
Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
[TBL] [Abstract][Full Text] [Related]
15. Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.
Rubio MA; Gargallo M; Isabel Millán A; Moreno B
Public Health Nutr; 2007 Oct; 10(10A):1200-5. PubMed ID: 17903331
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis.
Horvath K; Jeitler K; Siering U; Stich AK; Skipka G; Gratzer TW; Siebenhofer A
Arch Intern Med; 2008 Mar; 168(6):571-80. PubMed ID: 18362248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review].
Madsbad S
Ugeskr Laeger; 2011 Feb; 173(8):564-7. PubMed ID: 21333255
[TBL] [Abstract][Full Text] [Related]
19. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
Leung WY; Thomas GN; Chan JC; Tomlinson B
Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
